<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8709159</journal-id><journal-id journal-id-type="pubmed-jr-id">3902</journal-id><journal-id journal-id-type="nlm-ta">Free Radic Biol Med</journal-id><journal-id journal-id-type="iso-abbrev">Free Radic. Biol. Med.</journal-id><journal-title-group><journal-title>Free radical biology &#x00026; medicine</journal-title></journal-title-group><issn pub-type="ppub">0891-5849</issn><issn pub-type="epub">1873-4596</issn></journal-meta><article-meta><article-id pub-id-type="pmid">29723666</article-id><article-id pub-id-type="pmc">6381929</article-id><article-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.04.579</article-id><article-id pub-id-type="manuscript">NIHMS1519174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Metal exposure and oxidative stress markers in pregnant Navajo Birth Cohort Study participants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dashner-Titus</surname><given-names>Erica J.</given-names></name><!--<email>EDashner@salud.unm.edu</email>--><xref ref-type="aff" rid="A1">a</xref><xref ref-type="author-notes" rid="FN2">1</xref></contrib><contrib contrib-type="author"><name><surname>Hoover</surname><given-names>Joseph.</given-names></name><!--<email>JoHoover@salud.unm.edu</email>--><xref ref-type="aff" rid="A2">b</xref><xref ref-type="author-notes" rid="FN2">1</xref></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Li</given-names></name><!--<email>LLuo@salud.unm.edu</email>--><xref ref-type="aff" rid="A3">c</xref><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Ji-Hyun</given-names></name><!--<email>JiHyunLee@salud.unm.edu</email>--><xref ref-type="aff" rid="A3">c</xref><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Ruofei</given-names></name><!--<email>RDu@salud.unm.edu</email>--><xref ref-type="aff" rid="A3">c</xref><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ke Jian</given-names></name><!--<email>kliu@salud.unm.edu</email>--><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Traber</surname><given-names>Maret G</given-names></name><!--<email>maret.traber@oregonstate.edu</email>--><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Ho</surname><given-names>Emily</given-names></name><!--<email>Emily.Ho@oregonstate.edu</email>--><xref ref-type="aff" rid="A5">e</xref><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>Johnnye</given-names></name><!--<email>jlewis@cybermesa.com</email>--><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Hudson</surname><given-names>Laurie G.</given-names></name><!--<email>lhudson@salud.unm.edu</email>--><xref ref-type="aff" rid="A1">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM</aff><aff id="A2"><label>b</label>Community Environmental Health Program, College Of Pharmacy, University of New Mexico, 1 University of New Mexico, Albuquerque, NM 87131</aff><aff id="A3"><label>c</label>Biostatistics Shared Resource, The UNM Comprehensive Cancer Center, Albuquerque, NM, 87131, USA</aff><aff id="A4"><label>d</label>UNM METALS Biostatistics and Data Management (BDM) Core (Luo, Senior author for BDM team)</aff><aff id="A5"><label>e</label>Linus Pauling Institute, Oregon State University, 307 Linus Pauling Science Center, Corvallis, OR 97331</aff><aff id="A6"><label>f</label>Moore Family Center for Whole Grain Foods, Nutrition &#x00026; Preventive Health, School of Biological &#x00026; Population Health Sciences, College of Public Health &#x00026; Human Sciences, 211 Milam Hall, Oregon State University, Corvallis, OR 97331</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author.</corresp><fn fn-type="equal" id="FN2"><label>1</label><p id="P1">Authors contributed equally to the work and are listed alphabetically</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>15</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="ppub"><day>20</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>8</month><year>2019</year></pub-date><volume>124</volume><fpage>484</fpage><lpage>492</lpage><!--elocation-id from pubmed: 10.1016/j.freeradbiomed.2018.04.579--><abstract id="ABS1"><p id="P2">Contamination of soil and water by waste from abandoned uranium mines has led to chronic exposures to metal mixtures in Native American communities. Our previous work demonstrated that community exposures to mine waste increase the likelihood of developing cardiovascular disease, as well as the likelihood of developing multiple chronic diseases including diabetes, hypertension and kidney disease. Exposure to various environmental metals is associated with elevated oxidative stress, which is considered a contributor to these and other chronic disease states. The purpose of the current research was to assess potential associations between exposure to uranium and arsenic and evidence for increased oxidative stress as measured by urinary F<sub>2</sub>-isoprostanes in pregnant women enrolled in the Navajo Birth Cohort Study. The current study also included an analysis of zinc as a potential mediator of oxidative stress in the study population. Urinary arsenic and uranium, serum zinc and urinary F<sub>2</sub>-isoprostanes were measured for each study participant at enrollment. Study participants were pregnant women with median age of 26.8; 18.9 % were enrolled in the 1st trimester, 44.7% were enrolled in the 2nd trimester, and 36.4% were enrolled in the 3<sup>rd</sup> trimester. Median urinary metal levels were 5.5 and 0.016 &#x003bc;g/g creatinine for arsenic and uranium, respectively. Multivariable regression analysis indicated a significant association between arsenic exposure and the lipid peroxidation product 8-iso-prostaglandin F<sub>2&#x003b1;,</sub> controlling for zinc and trimester. No associations were detected with uranium despite evidence that levels were in the Navajo Birth Cohort samples were 2.3 times the median reported for women in the National Health and Nutrition Examination Survey (2011-12). Zinc was not found to have any causal mediation of the effects of the other metals on oxidative stress. The current work is consistent with other studies that have detected an association between arsenic and elevated oxidative stress. In contrast to arsenic, uranium did not appear to increase oxidative stress response in this study population. These findings are relevant to assessing the potential human impact of chronic exposure to mixed metal waste from abandoned uranium mines.</p></abstract><abstract id="ABS2" abstract-type="graphical"><title>Graphical abstract</title><p id="P3"><graphic xlink:href="nihms-1519174-f0001.jpg" position="anchor" orientation="portrait"/></p></abstract><kwd-group><kwd>Arsenic</kwd><kwd>uranium</kwd><kwd>zinc</kwd><kwd>oxidative stress</kwd><kwd>isoprostanes</kwd><kwd>Navajo Birth Cohort Study</kwd><kwd>AI/AN</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>INTRODUCTION</title><p id="P4">There are more than 4,000 abandoned uranium mines (AUMs<sup>9</sup>) in the Western United States [<xref rid="R1" ref-type="bibr">1</xref>] with more than 500 located on the Navajo Nation [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. These abandoned mine sites are often located in close proximity to Native American communities leading to community concerns about health impacts due to mine waste exposures. People may be exposed to AUM waste containing uranium, arsenic, and other co-occurring metals via air, soil or ground water [<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>]. On the Navajo Nation for example, more than 30% of the population lacks access to regulated public drinking water and must rely on unregulated water supplies or other sources for drinking water. A previous analysis of more than 500 unregulated water sources indicated that 15.1% and 12.8% of these unregulated sources exceeded national drinking water maximum contaminant levels (MCLs) for arsenic and uranium, respectively [<xref rid="R7" ref-type="bibr">7</xref>], providing potential exposure sources for arsenic and/or uranium. Navajo community members have expressed particular concern about uranium exposures [<xref rid="R9" ref-type="bibr">9</xref>]. Exposure to metals found in abandoned mine waste is associated with chronic disease occurrence among the Navajo and other Native American tribes. A survey of over 1300 people living on the Navajo Nation discovered that Navajo community members with ongoing community-level exposures to uranium mine waste have an increased likelihood of several chronic conditions such as cardiovascular disease, diabetes, and kidney disease [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>]. These findings suggest that chronic exposures to AUM waste affect human health.</p><p id="P5">Numerous chronic diseases, including cardiovascular and renal disease, are associated with elevated oxidative damage due to excess generation of reactive oxygen species [<xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R13" ref-type="bibr">13</xref>]. Experimental studies in cells and animal models link both arsenic [<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R18" ref-type="bibr">18</xref>] and uranium [<xref rid="R19" ref-type="bibr">19</xref>-<xref rid="R23" ref-type="bibr">23</xref>] to generation of oxidative stress. In contrast, studies to investigate the association between arsenic exposure and biomarkers of oxidative stress in human populations have not yielded consistent findings [<xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R34" ref-type="bibr">34</xref>] due in part to different study populations and detection methods for oxidative stress. The lack of studies on uranium exposure and direct biomarkers of oxidative stress is a gap in knowledge that limits our ability to understand the relationships between different metal exposures, oxidative stress and associated diseases in humans.</p><p id="P6">An ongoing cohort study on the Navajo Nation, the Navajo Birth Cohort Study (NBCS) [<xref rid="R35" ref-type="bibr">35</xref>], is examining the effects of uranium and other metal/metalloid exposures on birth outcomes and development. Currently there is limited information about the association between metal exposure and oxidative stress during pregnancy. In the NBCS, biomonitoring results indicate urine uranium concentrations exceed those in the US population, while serum zinc, a metal with antioxidant properties, is frequently below World Health Organization (WHO) recommended sufficiency concentrations [<xref rid="R3" ref-type="bibr">3</xref>]. This zinc deficiency has been observed in pregnant Navajo women for more than 35 years [<xref rid="R36" ref-type="bibr">36</xref>], but also occurs in men in the population. Therefore, samples from this study provide an opportunity to understand the effect of exposures to known metal inducers of oxidative damage on measures of oxidative stress, and test the hypothesis that zinc may have a potential modifying role in those responses.</p><p id="P7">Based on evidence from experimental models that arsenic and uranium exposures and zinc deficiency increase oxidative stress [<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R23" ref-type="bibr">23</xref>, <xref rid="R37" ref-type="bibr">37</xref>-<xref rid="R40" ref-type="bibr">40</xref>], the goal of the current study was to investigate the association between metal exposure and oxidative stress biomarkers, and determine whether serum zinc moderates the effects of these exposures. The lipid peroxidation product 8-iso-prostaglandin F<sub>2&#x003b1;</sub> (8-iso-PGF<sub>2&#x003b1;</sub>) was used as a urinary oxidative stress biomarker. Because 8-iso-PGF<sub>2&#x003b1;</sub> is also generated through an enzymatic pathway by prostaglandin-endoperoxide synthases, the ratio of 8-iso-PGF<sub>2&#x003b1;</sub> to prostaglandinF<sub>2&#x003b1;</sub> (PGF<sub>2&#x003b1;</sub>) has been established to distinguish enzymatic versus chemical lipid peroxidation as a biomarker of oxidative stress and was included in this study [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>]. We measured urinary arsenic and uranium, serum zinc and urinary F<sub>2</sub>-isoprostanes for 132 participants from the parent NBCS study. This group was then stratified by serum zinc concentrations (low vs. high) while preserving the range of uranium and arsenic found in the population to allow assessment of the impact of zinc on metal-associated oxidative stress. Metal values in the study population were compared to national values obtained from the National Health and Nutrition Examination Survey (NHANES) [<xref rid="R43" ref-type="bibr">43</xref>]. The reported findings provide insights into oxidative stress and exposure to metals associated with AUMs.</p></sec><sec id="S2"><title>MATERIALS AND METHODS</title><sec id="S3"><title>Study Overview</title><p id="P8">The study site, the Navajo Nation, is located in the Four Corners area of the southwestern United States. In 2013 the NBCS began recruiting pregnant women between 14 and 45 years of age who had lived on the Navajo Nation for at least 5 years, were willing to deliver at a participating hospital, and have their child followed up for one year postnatally. At the time of enrollment, a blood and urine sample was collected from the participant. Socioeconomic, demographic, and lifestyle information was also collected in the home shortly after enrollment. A subset of the maternal enrollment urine samples was selected for oxidative stress analysis, which forms the basis of this investigation.</p></sec><sec id="S4"><title>Study Population</title><p id="P9">The NBCS was initiated to address Navajo community concerns about how chronic environmental exposure to uranium mine waste affects human health. The research team led by the University of New Mexico (UNM) Health Sciences Center Community Environmental Health Program included partnerships with Navajo Nation Department of Health, Navajo Area Indian Health Service, Southwest Research Information Center and the US Centers for Disease Control and Prevention Agency for Toxic Substances and Disease Registry (CDC/ATSDR) National Center for Environmental Health (NCEH). Trained Indian Health Service staff recruited pregnant women during prenatal visits at one of six participating Indian Health Service or Public Law 638 hospitals on the Navajo Nation. The enrollment protocol prioritized recruitment of women during their 1<sup>st</sup> trimester but an open enrollment process was used, allowing women to enroll at any time during their pregnancy. For the present study, urine samples from NBCS participants were stratified by serum zinc concentration above and below the WHO level of sufficiency of 70 &#x003bc;g/dL. Additionally, we limited the sample population to individuals who also had their enrollment urine sample analyzed for uranium, total arsenic, arsenous (III) acid (arsenite, AsIII), and dimethylarsinic acid (DMA). Then we randomly selected 66 urine samples from each zinc group for inclusion in the present study out of 204 women enrolled in the NBCS at that time. Written informed consent was obtained from all study participants and the study protocol approved by the University of New Mexico Institutional Review Board (HRPO 11-310) and the Navajo Nation Human Research Review Board (NNR 11.323).</p></sec><sec id="S5"><title>Sample Collection and Preparation</title><p id="P10">Trained hospital staff collected biospecimen samples using pre-screened metal-free collection cups, transfer pipettes, and Nalgene cryo-vials provided by CDC NCEH Division of Laboratory Sciences (DLS). During a prenatal hospital appointment trained hospital staff collected spot urine samples in sterile 50 mL urine collection cup. After collection, a laboratory staff member transferred a 1.8 mL aliquot of urine to separate 2.0 mL Nalgene cryo-vials for multi-element metals, total arsenic, speciated arsenic, and creatinine analysis. Hospital laboratory staff also collected peripheral blood via venipuncture and then allowed the blood to clot at room temperature for 30 to 40 minutes. Once clotted laboratory staff centrifuged the blood tube at 2,400 revolutions per minute for 15 minutes to separate the serum and then transferred 1.8 mL aliquot of serum to a 2.0 mL Nalgene cryo-vial. After processing urine and serum samples, hospital staff placed all cryo-vials in a &#x02212;80&#x000b0;C freezer for storage and transferred on dry-ice to freezer storage facilities at UNM. Chain of Custody forms were completed, reviewed, and validated at each stage of collection, storage and analysis.</p></sec><sec id="S6"><title>Metal Biomonitoring Analysis</title><p id="P11">UNM staff shipped samples on dry ice to CDC DLS for analysis. NCEH laboratory staff prepared urine samples for uranium and other metals analyses using NCEH Method 3018.3; samples analyzed for total arsenic were prepared using Method 3018A.2 [<xref rid="R44" ref-type="bibr">44</xref>]; and samples analyzed for speciated arsenic were prepared using Method 3000.11 [<xref rid="R45" ref-type="bibr">45</xref>]. Chemical concentrations in urine and serum were measured using Inductively Coupled Plasma &#x02013; Dynamic Reaction Cell &#x02013; Mass Spectrometry (ICP-DRC-MS) [<xref rid="R46" ref-type="bibr">46</xref>]. Arsenic species concentrations were determined in separate aliquots using High Performance Liquid Chromatography (HPLC) and an anion exchange column to separate species prior to ICP-DRC-MS [<xref rid="R47" ref-type="bibr">47</xref>]. Urinary creatinine was determined using Roche/Hitachi Modular P Chemistry Analyzer [<xref rid="R48" ref-type="bibr">48</xref>].</p></sec><sec id="S7"><title>Measurement of Urinary Isoprostanes by HPLC-Tandem Mass Spectrometry</title><p id="P12">Analysis of urinary F2-isoprostanes and prostaglandin F2&#x003b1; in urine was performed by the Linus Pauling Institute Oxidative and Nitrative Stress Core Laboratory by HPLC-tandem mass spectrometry as described previously [<xref rid="R49" ref-type="bibr">49</xref>]. Creatinine was quantified in each sample by the same laboratory. Briefly, urine was thawed at room temperature, mixed by inversion, and centrifuged (200x <italic>g</italic>, 5 min). Aliquots of the supernatant were mixed with methanol and internal standards followed by addition of 0.02 M bis-tris-HCl. Samples were pH adjusted to 6.0 &#x02212;/+ 0.05. Strata X-AW cartridges (100 mg/3 mL, Phenomenex, Torrance, CA) were each pre-conditioned with methanol, then water. Diluted urine samples were loaded, the cartridges rinsed with sucsessively with methanol/water, acetonitrile and cartridges dried under a gentle vacuum (~5 mm Hg, 30 sec). Cartridges were then eluted 3-times with 1 mL methanol, and the eluants from each cartridge pooled and collected into glass tubes. Samples were dried under nitrogen gas, reconstituted in 200 &#x003bc;L methanol containing 0.1% formic acid (v:v), and injected onto the LC-MS-MS. Analytes were detected and quantified using SRM: F2-isoprostanes/prostaglandin F2&#x003b1;, <italic>m/z</italic> 353 to 193; 8-iso-PGF<sub>2&#x003b1;</sub>-d<sub>4</sub> internal standard, <italic>m/z</italic> 357 to 197. Samples were analyzed by HPLC-tandem mass spectrometry against standard curves for authentic standards [<xref rid="R49" ref-type="bibr">49</xref>].</p></sec><sec id="S8"><title>Statistical Methods</title><p id="P13">Summary statistics including median (interquartile range) for continuous variables and frequency (%) for categorical variables were used to describe the demographics, environmental characteristics, chemical exposures of urinary uranium, urinary total arsenic, DMA, AsIII, and serum zinc of the participants in the NBCS, overall and by zinc groups (&#x0003e; 70 vs &#x0003c; 70 &#x003bc;g/dL for high vs low categorical membership).</p><p id="P14">The urine chemical measurements were corrected for urine creatinine, and values below limit of detection (LOD) were replaced by the LOD value divided by 2. Wilcoxon rank-sum tests were used to compare continuous variables between zinc groups. Chi-squared tests and Fisher Exact tests for small expected numbers were performed to compare categorical variables between zinc groups. Pearson correlation coefficients along with the corresponding 95% confidence intervals (CIs) and scatterplots were used to summarize the correlation between log-transformed chemicals.</p><p id="P15">We compared the chemical exposures in the NBCS study to the national levels measured in women surveyed in the NHANES. The chemical exposure data were extracted from the NHANES year 2011-2012 database for women to represent the national population. Summary statistics of NHANES were calculated following the analysis guideline to account for the complex design features of NHANES including stratification, cluster sampling, and weighting [<xref rid="R50" ref-type="bibr">50</xref>].</p><p id="P16">Geometric mean along with 95% CIs were summarized for the chemical exposures in NBCS and the NHANES study. Statistical significance was determined using two-sample Welch's t-test comparing the mean (standard error) of the log transformed analytes, which took into account the NHANES design features.</p><p id="P17">The oxidative stress biomarkers as the primary outcomes include 8-iso-PGF<sub>2&#x003b1;</sub>, PGF<sub>2&#x003b1;</sub>, and the ratio of 8-iso-PGF<sub>2&#x003b1;</sub> to PGF<sub>2&#x003b1;</sub> to distinguish enzymatic versus chemical lipid peroxidation [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>]. Descriptive statistics were summarized for those variables by trimester at enrollment (1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup>). The measurements were corrected for urine creatinine and variables with skewed distributions were log transformed.</p><p id="P18">Univariable linear regression analyses were used to examine the association between each demographic variable and chemical exposure and the oxidative stress outcome (prostaglandin ratio or 8-iso-PGF<sub>2&#x003b1;</sub>). Multiple linear regression models for the oxidative stress biomarkers were used to evaluate the impact of chemical exposures while adjusting for other potential confounding covariates. Covariates evaluated in the analysis included: age at interview, pre-pregnancy body mass index (BMI), trimester at enrollment, educational attainment (above or below high school), household income (above or below $20,000), employment status (currently employed or not), alcohol in the past year (yes or no), tobacco smoking (never, current or former smoker), vitamin intake (yes or no), and use of wood or coal for home heating (yes or no). Linear models with a backwards variable selection method based on the Akaike information criterion (AIC) measure were used for assessing the effects of variables along with their interactions on the oxidative stress biomarker variables. We also performed multiple linear regression stratified by zinc groups to describe the different effects of urinary total arsenic on 8-iso-PGF<sub>2&#x003b1;</sub> moderated by high vs low zinc.</p><p id="P19">To assess the potential for zinc to mediate the effect of each metal (uranium, total arsenic, AsIII and DMA) on oxidative stress biomarkers (prostaglandin ratio and 8-iso- PGF<sub>2&#x003b1;</sub>), we used a quasi-Bayesian Monte Carlo causal mediation analysis [<xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R52" ref-type="bibr">52</xref>]. Covariates including trimester, education, household income, and tobacco were evaluated and adjusted for in the mediation analyses. We also then stratified this analysis by trimester to assess any confounding effects of changes in zinc across trimesters.</p><p id="P20">No adjustments for the multiple comparison tests were considered due to the discovery nature of this study. All analyses were conducted using the SAS 9.4 and R 3.4.1.</p></sec></sec><sec id="S9"><title>RESULTS</title><sec id="S10"><title>Selected Study Population Demographic Characteristics</title><p id="P21">Selected demographic characteristics for the subjects in this study are shown in <xref rid="T1" ref-type="table">Table 1</xref>. Study participants were drawn from the NBCS and all 132 participants included in this study were pregnant women between the ages of 16 to 42 with a median age of 26.8 years old. Analysis of survey information indicated that 38.6% of women had education beyond high school, 57.6% were unemployed and 43.2% had an annual household income below $20,000 at the time of study enrollment. The majority of women (59.8%) were taking vitamin supplements and were overweight or obese based on pre-pregnancy BMI (52.2%). Current cigarette smoking is negligible among the NBCS pregnant women (&#x0003c;1%) which is consistent with low tobacco usage overall in the Navajo population as reported previously by Redwood et al. [<xref rid="R53" ref-type="bibr">53</xref>]. However, other exposures such as wood or coal heating or use of ceremonial tobacco were noted as potential contributors to oxidative stress. The survey questions used to generate <xref rid="T1" ref-type="table">Table 1</xref> are provided in <xref rid="SD2" ref-type="supplementary-material">Supplemental Table 1</xref>.</p></sec><sec id="S11"><title>Metal Biomonitoring Characteristics of the Study Population</title><p id="P22">Urinary total arsenic, AsIII, DMA, uranium and serum zinc, were measured by ICP-DRC-MS as described in Materials and Methods (<xref rid="T2" ref-type="table">Table 2</xref>). Values for the same metals in women surveyed for the NHANES [<xref rid="R54" ref-type="bibr">54</xref>] are shown in <xref rid="T2" ref-type="table">Table 2</xref>. Of the 132 individuals in the sample population, urinary metals were detected among 132 (100%) for urinary total arsenic, 105 (79.5%) for urinary DMA, 88 (66.7%) for urinary AsIII, and 128 for urinary uranium (97.0%) (<xref rid="T2" ref-type="table">Table 2</xref>). Serum zinc was detected in 132 (100%) individuals from the sample population (<xref rid="T2" ref-type="table">Table 2</xref>). Total arsenic concentrations had a weak to moderate correlation with AsIII levels within the population (<xref rid="SD1" ref-type="supplementary-material">Supplemental Figure 1A</xref>), however, as expected, total arsenic correlated strongly with the metabolite DMA (<xref rid="SD1" ref-type="supplementary-material">Supplemental Figure 1B</xref>).</p><p id="P23">The median concentration for serum zinc was 67 &#x003bc;g/dL and median concentrations for urinary total arsenic, DMA, AsIII, and uranium were 5.5 &#x003bc;g/g, 4.3 &#x003bc;g/g, 0.41 &#x003bc;g/g, and 0.016 &#x003bc;g/g creatinine respectively. To provide context for the biomonitoring values, information for women was extracted from the NHANES 2011-12. Compared to the median for women included in the NHANES 2011-12 survey, urinary uranium was 2.3 times greater for NBCS samples (<xref rid="T2" ref-type="table">Table 2</xref>) with 88.6% and 15.9% of the sample population exceeding the NHANES 50<sup>th</sup> and 95<sup>th</sup> percentiles, respectively (<xref rid="SD3" ref-type="supplementary-material">Supplemental Table 2</xref>). Urine uranium concentrations for NBCS participants were greater than observed values from the NHANES study (p-value &#x0003c;0.001).</p><p id="P24">Urinary concentrations of total arsenic were lower for NBCS participants compared to NHANES values (p-value &#x0003c;0.001) (<xref rid="SD3" ref-type="supplementary-material">supplemental Table 2</xref>). Only 40.2% and 0.8% of NBCS participants had total arsenic urine concentrations exceeding the NHANES 50<sup>th</sup> and 95<sup>th</sup> percentiles, respectively. Serum concentrations of zinc were also lower in NBCS participants when compared to NHANES (p-value&#x0003c;0.001) (<xref rid="SD3" ref-type="supplementary-material">supplemental Table 2</xref>). No statistically significant difference was observed for DMA. Concentrations of urinary AsIII and serum zinc decreased from the 1<sup>st</sup> to 3<sup>rd</sup> trimester while concentrations of urinary uranium, total arsenic, and DMA remained stable (<xref rid="T3" ref-type="table">Table 3</xref>).</p><p id="P25">We observed no significant difference in urinary uranium or arsenic concentrations between the low versus high zinc groups suggesting that zinc status did not influence urinary metal levels (<xref rid="T2" ref-type="table">Table 2</xref>). The median concentration for the high zinc group was 78 &#x003bc;g/dL, which is similar to the NHANES values of 80 &#x003bc;g/dL and above the WHO sufficiency standard of 70 &#x003bc;g/dL. The median for the low zinc group was 48 &#x003bc;g/dL and well below the NHANES values and zinc sufficiency standard. The high and low zinc groups did not differ in the demographic characteristics with the exception of smoker classification. There were more Never Smokers and fewer Former Smokers in the low zinc group. Additionally, the high zinc group included more women who enrolled in the NBCS during the 1<sup>st</sup> trimester and low zinc group had more women enroll during the 3<sup>rd</sup> trimester (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec id="S12"><title>Characteristics of Oxidative Stress Biomarkers in the Study Population</title><p id="P26"><xref rid="T4" ref-type="table">Table 4</xref> provides the summary statistics for oxidative stress biomarkers as measured by HPLC-Tandem Mass Spectrometry. The biomarker 8-iso-PGF<sub>2&#x003b1;</sub> is a well-regarded marker for detection of chemical lipid peroxidation in human studies but does not take into account enzymatic contributions to total 8-iso-PGF<sub>2&#x003b1;</sub>. The use of a prostaglandin ratio (8-iso-PGF<sub>2&#x003b1;</sub> to PGF<sub>2&#x003b1;</sub>) has been described to overcome this issue [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>]. Of the oxidative stress biomarkers measured in this study, PGF<sub>2&#x003b1;</sub> and the prostaglandin ratio, but not 8-iso-PGF<sub>2&#x003b1;</sub>, were significantly different based on pregnancy trimester (<xref rid="T4" ref-type="table">Table 4</xref>). When only zinc is considered, comparison between the low and high zinc status subsets revealed no difference in the oxidative stress biomarkers 8-iso-PGF<sub>2&#x003b1;</sub> or the prostaglandin ratio (<xref rid="F1" ref-type="fig">Figure 1</xref>). The urinary 8-iso-PGF<sub>2&#x003b1;</sub> levels measured in this study are comparable to previous reports in pregnant populations [<xref rid="R55" ref-type="bibr">55</xref>, <xref rid="R56" ref-type="bibr">56</xref>]. Based on findings that the isoprostane metabolites dinorF1 and F2 values were subject to variability between different batch analyses (data not shown), only 8-iso-PGF<sub>2&#x003b1;</sub>, PGF<sub>2&#x003b1;</sub> and the prostaglandin ratio were included for the regression models.</p><p id="P27">Ceremonial tobacco use was associated significantly with higher levels 8-iso-PGF<sub>2&#x003b1;</sub> and prostaglandin ratio oxidative stress markers (Supplemental Tables <xref rid="SD4" ref-type="supplementary-material">3</xref> and <xref rid="SD5" ref-type="supplementary-material">4</xref>). In addition, significantly lower 8-iso-PGF<sub>2&#x003b1;</sub> levels were observed in populations with a household income above $20,000 and education above high school (<xref rid="SD4" ref-type="supplementary-material">Supplemental Table 3</xref>). The prostaglandin ratio was significantly affected by trimester stage (<xref rid="SD5" ref-type="supplementary-material">Supplemental Table 4</xref>).</p></sec><sec id="S13"><title>Associations between metals and oxidative stress biomarkers</title><p id="P28">In a univariable analysis of the linear regression model there were no significant associations with environmental metals and 8-iso-PGF<sub>2&#x003b1;</sub> (<xref rid="T5" ref-type="table">Table 5</xref>). Of the potential confounders, low income and ceremonial tobacco use had a significant association with urinary 8-iso-PGF<sub>2&#x003b1;</sub> in the univariable analysis (<xref rid="T5" ref-type="table">Table 5</xref>). A multivariable analysis revealed significant main effects and interaction effects between total arsenic and low zinc on the 8-iso-PGF<sub>2&#x003b1;</sub> outcome (<xref rid="T5" ref-type="table">Table 5</xref>).</p><p id="P29">The findings differed when using the prostaglandin ratio as the oxidative stress biomarker. In the univariable analysis there was a positive association with the arsenic metabolite DMA, but not other metals (<xref rid="T6" ref-type="table">Table 6</xref>) and a marginal positive association between total arsenic and the prostaglandin ratio was observed in the multivariable analysis. Notably, different sets of confounding variables were identified for each of the oxidative stress biomarkers. For example, pregnancy trimester was identified as a confounding variable for the prostaglandin ratio but not for 8-iso-PGF<sub>2&#x003b1;</sub> alone (<xref rid="T6" ref-type="table">Table 6</xref>). This can be accounted for by the lack of significant difference of 8-iso-PGF<sub>2&#x003b1;</sub> by trimester whereas PGF<sub>2&#x003b1;</sub> was significantly increased as pregnancy progressed from 1<sup>st</sup> to 3<sup>rd</sup> trimester (<xref rid="T4" ref-type="table">Table 4</xref>).</p><p id="P30">In order to better understand the arsenic and zinc interaction term from <xref rid="T5" ref-type="table">Table 5</xref>, we ran the stratified multivariable analysis by serum zinc group. We observed that the association between total arsenic and oxidative stress was modified by zinc group. Specifically, arsenic was positively associated with increased 8-iso-PGF<sub>2&#x003b1;</sub> for the high serum zinc group, but not for the low serum zinc group (<xref rid="T7" ref-type="table">Table 7</xref>). In terms of the mediation effect of zinc on the association or metal/metalloids with oxidative stress, the causal mediation analysis (Materials and Methods) yielded no significant results of zinc mediation.</p></sec></sec><sec id="S14"><title>DISCUSSION</title><p id="P31">The Navajo Nation was a site of extensive uranium mining for more than 40 years [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R35" ref-type="bibr">35</xref>] and even in the absence of current active mining, potential exposures persist through proximity to AUMs, and water and soil contamination [<xref rid="R57" ref-type="bibr">57</xref>]. Uranium and arsenic were the focus of this study based on the prevalence of these metals in AUM waste, elevated levels in many water sources on Navajo land [<xref rid="R7" ref-type="bibr">7</xref>] and biomonitoring evidence indicating elevated uranium exposures in individuals [<xref rid="R9" ref-type="bibr">9</xref>]. Both metals have been reported to induce oxidative stress in experimental models [<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R23" ref-type="bibr">23</xref>], although the specific mechanisms that might be pertinent to a human population at environmental levels are currently unknown. Numerous studies link exposures to uranium or arsenic or mixed metals to a multitude of adverse health effects such as renal, cardiovascular and immune diseases [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R58" ref-type="bibr">58</xref>-<xref rid="R63" ref-type="bibr">63</xref>]. Although oxidative stress is viewed as a mechanism underlying many metal-associated adverse health effects, there is limited knowledge regarding the potential association between uranium exposure and oxidative stress in human populations.Understanding potential roles of environmental metal exposure and oxidative stress during pregnancy is important because oxidative stress has been implicated in various pregnancy disorders, most notably pre-eclampsia and preterm labor [<xref rid="R64" ref-type="bibr">64</xref>].</p><p id="P32">The median urinary uranium levels in this study population were more than double those reported in the general US population based on NHANES data, yet no significant association between uranium and the oxidative stress biomarkers was detected. This finding is consistent with experimental studies where concentrations of uranium at or above 100 &#x003bc;M were required to elicit a measureable oxidative stress response [<xref rid="R19" ref-type="bibr">19</xref>-<xref rid="R23" ref-type="bibr">23</xref>] and suggests that the level of uranium exposure in these NBCS participants is below the threshold for detectable increase in oxidative stress.</p><p id="P33">We identified a significant positive association between urinary total arsenic and the oxidative stress biomarker 8-iso PGF<sub>2&#x003b1;</sub> in a multivariable analysis. This finding is in agreement with several other population studies investigating arsenic exposure and oxidative stress, but results vary across studies. Positive associations between arsenic exposure and the urinary oxidative stress markers of DNA damage (8-oxodG or 8-OHdG) [<xref rid="R26" ref-type="bibr">26</xref>, <xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R32" ref-type="bibr">32</xref>-<xref rid="R34" ref-type="bibr">34</xref>] or 8-iso PGF<sub>2&#x003b1;</sub> [<xref rid="R34" ref-type="bibr">34</xref>] have been reported. A study in children found a positive correlation between arsenic exposure and salivary 8-OHdG, but not urinary 8-OHdG [<xref rid="R24" ref-type="bibr">24</xref>] and a dose relationship study based on different arsenic exposures failed to identify a significant association between arsenic and protein carbonyl or 8-oxo-2&#x02019;-deoxyguanosine levels [<xref rid="R28" ref-type="bibr">28</xref>]. Another study found the strongest association between 8-oxodG and percent monomethylarsonic acid (MMA) compared to a weak association with urinary inorganic arsenic [<xref rid="R29" ref-type="bibr">29</xref>]. Those authors proposed that the differences from other reported findings may have been due to differences in arsenic metabolism in their indigenous study population [<xref rid="R29" ref-type="bibr">29</xref>]. Despite differences in study populations in terms of age, ethnicity, gender, pregnancy status and other factors, as well as lack of uniformity in specific oxidative stress biomarkers selected overall, our findings in the NBCS participants and those reported in the literature provide evidence of arsenic-associated elevation of oxidative stress in humans.</p><p id="P34">In this study we hypothesized that zinc status would have an impact on metal-associated oxidative stress based on the antioxidant properties of zinc [<xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R66" ref-type="bibr">66</xref>]. However, we did not obtain definitive evidence that zinc mediated the arsenic effect with regard to the oxidative stress biomarker 8-iso-PGF<sub>2&#x003b1;</sub>. One possible explanation is the impact of pregnancy on zinc status. Decreased serum zinc is common in pregnancy with reported mean values of approximately 58-60 &#x003bc;g/dL at term [<xref rid="R66" ref-type="bibr">66</xref>-<xref rid="R69" ref-type="bibr">69</xref>]. During pregnancy, women with serum zinc values &#x0003c;56 &#x003bc;g/dL are considered zinc deficient [<xref rid="R70" ref-type="bibr">70</xref>] and the mean serum zinc value in the NBCS study participants was below this definition of zinc sufficiency. Multivariable analysis using the standard biomarker 8-iso-PGF<sub>2&#x003b1;</sub> revealed a positive association between low serum zinc and elevated oxidative stress as has been reported previously in adults [<xref rid="R66" ref-type="bibr">66</xref>, <xref rid="R71" ref-type="bibr">71</xref>].</p><p id="P35">The biomarker 8-iso-PGF<sub>2&#x003b1;</sub> is considered the best fatty acid indicator of oxidative stress <italic>in vivo</italic> [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R72" ref-type="bibr">72</xref>] and is widely used in human studies. One caveat is that cyclooxygenases 1 &#x00026; 2 can contribute to the formation of 8-iso-PGF<sub>2&#x003b1;</sub> independent of oxidative stress stimuli. Recent studies in humans and animal models suggest that the prostaglandin ratio of 8-iso-PGF<sub>2&#x003b1;</sub>/PGF<sub>2&#x003b1;</sub> is a better indicator of oxidative stress because it accounts for changes in biosynthesis pathways [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R42" ref-type="bibr">42</xref>]. In this study we compared 8-iso-PGF<sub>2&#x003b1;</sub> or the prostaglandin ratio as the oxidative stress biomarker variables and noted differences based on the biomarker used. For example, in the linear regression models pregnancy trimester was significantly associated with oxidative stress when the prostaglandin ratio was used as the biomarker variable. This association was absent when 8-iso-PGF<sub>2&#x003b1;</sub> alone was the biomarker variable. We found that PGF<sub>2&#x003b1;</sub>, but not 8-iso-PGF<sub>2&#x003b1;</sub>, levels increased as pregnancy advanced which is consistent with other findings that oxidative stress increases with pregnancy [<xref rid="R55" ref-type="bibr">55</xref>, <xref rid="R56" ref-type="bibr">56</xref>]. This comparison provides an example of the potential value of incorporating the prostaglandin ratio into analyses of F<sub>2</sub>-isoprostanes as biomarkers of oxidative stress in addition to the more standard use of 8-iso-PGF<sub>2&#x003b1;</sub>. Use of both markers would allow for comparison of findings with established literature and expand understanding of the benefits of the ratio especially under conditions or in populations were endogenous contributions to total production of 8-iso-PGF<sub>2&#x003b1;</sub> may be an important factor.</p><p id="P36">Very few demographic characteristics were associated with either oxidative stress biomarker, but ceremonial tobacco use was significant in the regression models. Ceremonial tobacco use is associated with traditional practices and may reflect complex exposures from the local plant sources or other aspects of cultural ceremonies incorporating this product. Although we do not know how or why intermittent ceremonial tobacco use might be associated with systemic oxidative stress, this example highlights the importance of taking into consideration culture and local practices in studies of indigenous populations.</p><p id="P37">Challenges in this study include the relative paucity of data in the Navajo population, limited published information on metals and oxidative stress in pregnant women, and the NHANES sample not being representative of many aspects of our study group including a sufficient numbers of Native Americans for comparison. While NHANES values are representative of the overall US population, the survey is not designed to assess pregnant women specifically. During the 2011-12 NHANES cycle for example, less than 5% of participating women had a clinically confirmed pregnancy. Pregnancy results in changes to urinary excretion of metals and decreases in serum zinc concentrations. For example, previous work has demonstrated that the prevalence of arsenic species changes throughout pregnancy due to greater methylation [<xref rid="R73" ref-type="bibr">73</xref>]. Additionally, previous work has indicated that pregnant women have lower serum zinc concentrations than the general population because increased copper absorption interferes with zinc absorption [<xref rid="R74" ref-type="bibr">74</xref>]. No information about changes in uranium excretion throughout pregnancy is available. Therefore, the representative NHANES values may not fully represent urinary or serum concentrations of pregnant women in the United States but it remains the only large sample data set using consistent, high quality, and comparable analytical methods to use for comparison of population biomonitoring data. This study was focused on metals (arsenic and uranium) known to exceed the MCL in local water sources. Future studies may include additional metals in relation to biomarkers of oxidative stress.</p><p id="P38">In conclusion, we find evidence for elevated urinary uranium in women enrolled in the NBCS when compared to NHANES values, but no corresponding increase in oxidative stress measures associated with uranium. In contrast, arsenic is associated with increased levels of urinary 8-iso-PGF<sub>2&#x003b1;</sub> as has been reported in other populations. Despite established antioxidant properties of zinc, zinc was not found to have causal mediation of the effects of the other metals on oxidative stress. Direct comparison of the prostaglandin ratio versus 8-iso-PGF<sub>2&#x003b1;</sub> alone as biomarkers of oxidative stress reveals the utility of the prostaglandin ratio for studies of populations with known underlying factors, such as pregnancy, that may affect oxidative stress measurements.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS1519174-supplement-1.pptx" orientation="portrait" xlink:type="simple" id="d36e949" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>2</label><media xlink:href="NIHMS1519174-supplement-2.xlsx" orientation="portrait" xlink:type="simple" id="d36e953" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>3</label><media xlink:href="NIHMS1519174-supplement-3.xlsx" orientation="portrait" xlink:type="simple" id="d36e957" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>4</label><media xlink:href="NIHMS1519174-supplement-4.xlsx" orientation="portrait" xlink:type="simple" id="d36e961" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>5</label><media xlink:href="NIHMS1519174-supplement-5.xlsx" orientation="portrait" xlink:type="simple" id="d36e965" position="anchor"/></supplementary-material></sec></body><back><ack id="S15"><title>ACKNOWLEDGEMENTS</title><p id="P39">This work was supported by the National Institutes of Health [Competing Revision to 1R01ES021100 NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01); Navajo Birth Cohort Study: CDC/NCEH/ATSDR 5 U01 TS000135-05 and 1P50ES026102 UNM Center for Native Environmental Health Equity NIEHS/NIMHD P50ES026102 &#x00026; USEPA (#83615701). Additional support for Shared Resources was provided by 2P30 CA118100 UNM Comprehensive Cancer Center NCI and training support for Drs. Hoover and Dashner by 5K12GM088021-08 Academic Science Education and Research Training (ASERT) Program and support from the Oregon Agricultural Experimental Research Station. We also acknowledge the expertise of Dr. Jaewoo Choi and Scott Leonard of the Linus Pauling Institute for the analysis of urinary isoprostanes.</p><p id="P40">This material was developed in part under Assistance Agreement No. 83615701 awarded by the U.S. Environmental Protection Agency to the University of New Mexico Health Sciences Center. It has not been formally reviewed by EPA. The views expressed are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.</p><p id="P41">A portion of the research reported in this publication was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number P50ES026102. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p><p id="P42">We would like to acknowledge all of our indigenous partners we have had the pleasure of working with over the last three decades and from whom we have learned about the lasting impact of the abandoned mines, with particular acknowledgement of those from Tachee/Blue Gap and Red Water Pond Road communities on Navajo, the 1304 families in our original DiNEH Project, and the more than 750 families currently in the Navajo Birth Cohort Study. We also acknowledge the partnership of our research partners from Southwest Research and Information Center and their Navajo Home Environmental Assessment staff, Navajo Nation Department of Health including Mae-Gilene Begay and the Community Health and Environmental Research Specialists, Navajo Nation Environmental Protection Agency, and faculty and staff from the UNM METALS team including Dr. David Begay of CEHP for his support in understanding Navajo culture and tradition. Finally, all Navajo Nation research is reviewed and monitored by the Navajo Nation Human Research Review Board.</p></ack><fn-group><fn id="FN1"><p id="P43" content-type="publisher-disclaimer">This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></fn></fn-group><glossary><title>Abbreviations<sup>9</sup></title><def-list><def-item><term>8-iso-PGF<sub>2&#x003b1;</sub></term><def><p id="P44">8-iso prostaglandin F<sub>2&#x003b1;</sub></p></def></def-item><def-item><term>AsIII</term><def><p id="P45">arsenite</p></def></def-item><def-item><term>AUM</term><def><p id="P46">abandoned uranium mine</p></def></def-item><def-item><term>ATSDR</term><def><p id="P47">Agency for Toxic Substances and Disease Registry</p></def></def-item><def-item><term>BMI</term><def><p id="P48">Body Mass Index</p></def></def-item><def-item><term>CDC</term><def><p id="P49">Center for Disease Control and Prevention</p></def></def-item><def-item><term>CI</term><def><p id="P50">confidence interval</p></def></def-item><def-item><term>DLS</term><def><p id="P51">Division of Laboratory Sciences</p></def></def-item><def-item><term>DMA</term><def><p id="P52">dimethylarsinic acid</p></def></def-item><def-item><term>HPLC</term><def><p id="P53">High Performance Liquid Chromatography</p></def></def-item><def-item><term>ICP-DRC-MS</term><def><p id="P54">Inductively Coupled Plasma &#x02013; Dynamic Reaction Cell &#x02013; Mass Spectrometry</p></def></def-item><def-item><term>IQR</term><def><p id="P55">interquartile range</p></def></def-item><def-item><term>LOD</term><def><p id="P56">Limit of Detection</p></def></def-item><def-item><term>MCL</term><def><p id="P57">Maximum Contaminant Level</p></def></def-item><def-item><term>NBCS</term><def><p id="P58">Navajo Birth Cohort Study</p></def></def-item><def-item><term>NCEH</term><def><p id="P59">National Center for Environmental Health</p></def></def-item><def-item><term>NHANES</term><def><p id="P60">National Health and Nutrition Examination Survey</p></def></def-item><def-item><term>PGF<sub>2&#x003b1;</sub></term><def><p id="P61">prostaglandin F<sub>2&#x003b1;</sub></p></def></def-item><def-item><term>UNM</term><def><p id="P62">University of New Mexico</p></def></def-item><def-item><term>WHO</term><def><p id="P63">World Health Organization</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="book"><collab>Agency, U.S.E.P.</collab>, <source>Technical Report on Technologically Enhanced NAturally Occuring Radioactive Materials from Uranium Mining</source>, <publisher-name>R.P.D. Office of Radiation and Indoor Air</publisher-name>, Editor. <year>2008</year>: <publisher-loc>Washington DC</publisher-loc>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><collab>Agency, U.S.E.P.</collab>, <source>Health and Environmental Impacts of Uranium Contamination in the Navajo Nation Five-Year Plan</source>. <year>2016</year>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>J</given-names></name>, <etal/>, <article-title>Environmental exposures to metals in Native communities and implications for child development: basis for the Navajo birth cohort study</article-title>. <source>J Soc Work Disabil Rehabil</source>, <year>2015</year>
<volume>14</volume>(<issue>3-4</issue>): p. <fpage>245</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">26151586</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Blake</surname><given-names>JM</given-names></name>, <etal/>, <article-title>Elevated Concentrations of U and Co-occurring Metals in Abandoned Mine Wastes in a Northeastern Arizona Native American Community</article-title>. <source>Environ Sci Technol</source>, <year>2015</year>
<volume>49</volume>(<issue>14</issue>): p. <fpage>8506</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">26158204</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Corlin</surname><given-names>L</given-names></name>, <etal/>, <article-title>Health Effects and Environmental Justice Concerns of Exposure to Uranium in Drinking Water</article-title>. <source>Curr Environ Health Rep</source>, <year>2016</year>
<volume>3</volume>(<issue>4</issue>): p. <fpage>434</fpage>&#x02013;<lpage>442</lpage>.<pub-id pub-id-type="pmid">27815781</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Orescanin</surname><given-names>V</given-names></name>, <etal/>, <article-title>Characterization and treatment of water used for human consumption from six sources located in the Cameron/Tuba City abandoned uranium mining area</article-title>. <source>J Environ Sci Health A Tox Hazard Subst Environ Eng</source>, <year>2011</year>
<volume>46</volume>(<issue>6</issue>): p. <fpage>627</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">21547818</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Hoover</surname><given-names>J</given-names></name>, <etal/>, <article-title>Elevated Arsenic and Uranium Concentrations in Unregulated Water Sources on the Navajo Nation, USA</article-title>. <source>Expo Health</source>, <year>2017</year>
<volume>9</volume>(<issue>2</issue>): p. <fpage>113</fpage>&#x02013;<lpage>124</lpage>.<pub-id pub-id-type="pmid">28553666</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Hund</surname><given-names>L</given-names></name>, <etal/>, <article-title>A Bayesian framework for estimating disease risk due to exposure to uranium mine and mill waste on the Navajo Nation</article-title>. <source>Journal of the Royal Statistical Society</source>, <year>2015</year>
<volume>178</volume>(<issue>4</issue>): p. <fpage>1069</fpage>&#x02013;<lpage>1091</lpage>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>J</given-names></name>, <name><surname>Hoover</surname><given-names>J</given-names></name>, and <name><surname>MacKenzie</surname><given-names>D</given-names></name>, <article-title>Mining and Environmental Health Disparities in Native American Communities</article-title>. <source>Curr Environ Health Rep</source>, <year>2017</year>
<volume>4</volume>(<issue>2</issue>): p. <fpage>130</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">28447316</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Il'yasova</surname><given-names>D</given-names></name>, <name><surname>Scarbrough</surname><given-names>P</given-names></name>, and <name><surname>Spasojevic</surname><given-names>I</given-names></name>, <article-title>Urinary biomarkers of oxidative status</article-title>. <source>Clin Chim Acta</source>, <year>2012</year>
<volume>413</volume>(<issue>19-20</issue>): p. <fpage>1446</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">22683781</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Frijhoff</surname><given-names>J</given-names></name>, <etal/>, <article-title>Clinical Relevance of Biomarkers of Oxidative Stress</article-title>. <source>Antioxid Redox Signal</source>, <year>2015</year>
<volume>23</volume>(<issue>14</issue>): p. <fpage>1144</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">26415143</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Deeb</surname><given-names>RS</given-names></name> and <name><surname>Hajjar</surname><given-names>DP</given-names></name>, <article-title>Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease</article-title>. <source>Am J Pathol</source>, <year>2016</year>
<volume>186</volume>(<issue>7</issue>): p. <fpage>1736</fpage>&#x02013;<lpage>1749</lpage>.<pub-id pub-id-type="pmid">27171899</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Ratliff</surname><given-names>BB</given-names></name>, <etal/>, <article-title>Oxidant Mechanisms in Renal Injury and Disease</article-title>. <source>Antioxid Redox Signal</source>, <year>2016</year>
<volume>25</volume>(<issue>3</issue>): p. <fpage>119</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">26906267</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Valko</surname><given-names>M</given-names></name>, <etal/>, <article-title>Redox- and non-redox-metal-induced formation of free radicals and their role in human disease</article-title>. <source>Arch Toxicol</source>, <year>2016</year>
<volume>90</volume>(<issue>1</issue>): p. <fpage>1</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">26343967</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Flora</surname><given-names>SJ</given-names></name>, <article-title>Arsenic-induced oxidative stress and its reversibility</article-title>. <source>Free Radic Biol Med</source>, <year>2011</year>
<volume>51</volume>(<issue>2</issue>): p. <fpage>257</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">21554949</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Jomova</surname><given-names>K</given-names></name>, <etal/>, <article-title>Arsenic: toxicity, oxidative stress and human disease</article-title>. <source>J Appl Toxicol</source>, <year>2011</year>
<volume>31</volume>(<issue>2</issue>): p. <fpage>95</fpage>&#x02013;<lpage>107</lpage>.<pub-id pub-id-type="pmid">21321970</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>KL</given-names></name>, <name><surname>Liu</surname><given-names>KJ</given-names></name>, and <name><surname>Hudson</surname><given-names>LG</given-names></name>, <article-title>Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase</article-title>. <source>Free Radic Biol Med</source>, <year>2009</year>
<volume>47</volume>(<issue>4</issue>): p. <fpage>381</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19414066</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>H</given-names></name>, <name><surname>Hudson</surname><given-names>LG</given-names></name>, and <name><surname>Liu</surname><given-names>KJ</given-names></name>, <article-title>Oxidative stress and apoptosis in metal ion-induced carcinogenesis</article-title>. <source>Free Radic Biol Med</source>, <year>2004</year>
<volume>37</volume>(<issue>5</issue>): p. <fpage>582</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">15288116</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Periyakaruppan</surname><given-names>A</given-names></name>, <etal/>, <article-title>Uranium induces oxidative stress in lung epithelial cells</article-title>. <source>Arch Toxicol</source>, <year>2007</year>
<volume>81</volume>(<issue>6</issue>): p. <fpage>389</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">17124605</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Gagnaire</surname><given-names>B</given-names></name>, <etal/>, <article-title>Effects of depleted uranium on oxidative stress, detoxification, and defence parameters of zebrafish Danio rerio</article-title>. <source>Arch Environ Contam Toxicol</source>, <year>2013</year>
<volume>64</volume>(<issue>1</issue>): p. <fpage>140</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">23052361</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Garmash</surname><given-names>SA</given-names></name>, <etal/>, <article-title>Pro-oxidative, genotoxic and cytotoxic properties of uranyl ions</article-title>. <source>J Environ Radioact</source>, <year>2014</year>
<volume>127</volume>: p. <fpage>163</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">23312590</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>J</given-names></name>, <etal/>, <article-title>Hydrogen sulfide (H2S) attenuates uranium-induced acute nephrotoxicity through oxidative stress and inflammatory response via Nrf2-NF-kappaB pathways</article-title>. <source>Chem Biol Interact</source>, <year>2015</year>
<volume>242</volume>: p. <fpage>353</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">26523793</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>Y</given-names></name>, <etal/>, <article-title>Ghrelin protects against depleted uranium-induced apoptosis of MC3T3-E1 cells through oxidative stress-mediated p38-mitogen-activated protein kinase pathway</article-title>. <source>Toxicol Appl Pharmacol</source>, <year>2016</year>
<volume>290</volume>: p. <fpage>116</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">26529667</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Hinhumpatch</surname><given-names>P</given-names></name>, <etal/>, <article-title>Oxidative DNA damage and repair in children exposed to low levels of arsenic in utero and during early childhood: application of salivary and urinary biomarkers</article-title>. <source>Toxicol Appl Pharmacol</source>, <year>2013</year>
<volume>273</volume>(<issue>3</issue>): p. <fpage>569</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">24128852</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Pei</surname><given-names>Q</given-names></name>, <etal/>, <article-title>Oxidative DNA damage of peripheral blood polymorphonuclear leukocytes, selectively induced by chronic arsenic exposure, is associated with extent of arsenic-related skin lesions</article-title>. <source>Toxicol Appl Pharmacol</source>, <year>2013</year>
<volume>266</volume>(<issue>1</issue>): p. <fpage>143</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23142755</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Y</given-names></name>, <etal/>, <article-title>Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults</article-title>. <source>Toxicol Appl Pharmacol</source>, <year>2008</year>
<volume>232</volume>(<issue>1</issue>): p. <fpage>142</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">18640141</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>De Vizcaya-Ruiz</surname><given-names>A</given-names></name>, <etal/>, <article-title>Biomarkers of oxidative stress and damage in human populations exposed to arsenic</article-title>. <source>Mutat Res</source>, <year>2009</year>
<volume>674</volume>(<issue>1-2</issue>): p. <fpage>85</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">18984063</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Harper</surname><given-names>KN</given-names></name>, <etal/>, <article-title>A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh</article-title>. <source>J Occup Environ Med</source>, <year>2014</year>
<volume>56</volume>(<issue>6</issue>): p. <fpage>652</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24854259</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Engstrom</surname><given-names>KS</given-names></name>, <etal/>, <article-title>Low 8-oxo-7,8-dihydro-2'-deoxyguanosine levels and influence of genetic background in an Andean population exposed to high levels of arsenic</article-title>. <source>Mutat Res</source>, <year>2010</year>
<volume>683</volume>(<issue>1-2</issue>): p. <fpage>98</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">19896490</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Engstrom</surname><given-names>KS</given-names></name>, <etal/>, <article-title>Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7,8-dihydro-2'-deoxyguanosine in urine</article-title>. <source>Free Radic Biol Med</source>, <year>2010</year>
<volume>48</volume>(<issue>9</issue>): p. <fpage>1211</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">20153423</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Burgess</surname><given-names>JL</given-names></name>, <etal/>, <article-title>Environmental Arsenic Exposure and Urinary 8-OHdG in Arizona and Sonora</article-title>. <source>Clin Toxicol (Phila)</source>, <year>2007</year>
<volume>45</volume>(<issue>5</issue>): p. <fpage>490</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17503254</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>S</given-names></name>, <etal/>, <article-title>Trace elements are associated with urinary 8-hydroxy-2'-deoxyguanosine level: a case study of college students in Guangzhou, China</article-title>. <source>Environ Sci Pollut Res Int</source>, <year>2016</year>
<volume>23</volume>(<issue>9</issue>): p. <fpage>8484</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">26782679</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Kubota</surname><given-names>R</given-names></name>, <etal/>, <article-title>Urinary 8-hydroxy-2'-deoxyguanosine in inhabitants chronically exposed to arsenic in groundwater in Cambodia</article-title>. <source>J Environ Monit</source>, <year>2006</year>
<volume>8</volume>(<issue>2</issue>): p. <fpage>293</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16470262</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>T</given-names></name>, <etal/>, <article-title>The effects of heavy metals and their interactions with polycyclic aromatic hydrocarbons on the oxidative stress among coke-oven workers</article-title>. <source>Environ Res</source>, <year>2015</year>
<volume>140</volume>: p. <fpage>405</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">25956561</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Hunter</surname><given-names>CM</given-names></name>, <etal/>, <article-title>The Navajo Birth Cohort Study</article-title>. <source>J Environ Health</source>, <year>2015</year>
<volume>78</volume>(<issue>2</issue>): p. <fpage>42</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">26502566</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Butte</surname><given-names>NF</given-names></name>, <name><surname>Calloway</surname><given-names>DH</given-names></name>, and <name><surname>Van Duzen</surname><given-names>JL</given-names></name>, <article-title>Nutritional assessment of pregnant and lactating Navajo women</article-title>. <source>Am J Clin Nutr</source>, <year>1981</year>
<volume>34</volume>(<issue>10</issue>): p. <fpage>2216</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">7293950</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Bruno</surname><given-names>RS</given-names></name>, <etal/>, <article-title>Dietary zinc restriction in rats alters antioxidant status and increases plasma F2 isoprostanes</article-title>. <source>J Nutr Biochem</source>, <year>2007</year>
<volume>18</volume>(<issue>8</issue>): p. <fpage>509</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">17142032</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Kloubert</surname><given-names>V</given-names></name> and <name><surname>Rink</surname><given-names>L</given-names></name>, <article-title>Zinc as a micronutrient and its preventive role of oxidative damage in cells</article-title>. <source>Food Funct</source>, <year>2015</year>
<volume>6</volume>(<issue>10</issue>): p. <fpage>3195</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">26286461</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Oteiza</surname><given-names>PI</given-names></name>, <article-title>Zinc and the modulation of redox homeostasis</article-title>. <source>Free Radic Biol Med</source>, <year>2012</year>
<volume>53</volume>(<issue>9</issue>): p. <fpage>1748</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">22960578</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Prasad</surname><given-names>AS</given-names></name>, <article-title>Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health</article-title>. <source>Front Nutr</source>, <year>2014</year>
<volume>1</volume>: p. <fpage>14</fpage>.<pub-id pub-id-type="pmid">25988117</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>van 't Erve</surname><given-names>TJ</given-names></name>, <etal/>, <article-title>Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2alpha)/PGF(2alpha) ratio distinguishes chemical from enzymatic lipid peroxidation</article-title>. <source>Free Radic Biol Med</source>, <year>2015</year>
<volume>83</volume>: p. <fpage>245</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">25772010</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Van't Erve</surname><given-names>TJ</given-names></name>, <etal/>, <article-title>Reinterpreting the best biomarker of oxidative stress: The 8-iso-prostaglandin F2alpha/prostaglandin F2alpha ratio shows complex origins of lipid peroxidation biomarkers in animal models</article-title>. <source>Free Radic Biol Med</source>, <year>2016</year>
<volume>95</volume>: p. <fpage>65</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">26964509</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="book"><collab>Prevention, C.f.D.C.a.</collab>, <source>National Health and Nutrition Examination Survey Data</source>, <publisher-name>N.C.f.H. Statistics</publisher-name>, Editor. <year>2011-2012</year>: <publisher-loc>Hyattsville, MD</publisher-loc>.</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <article-title>Laboratory Procedure Manual</article-title>, <source>Multi-Element ICP-DRC-MS Renamed from &#x0201c;Inductively Coupled Plasma-Mass Spectrometry (ICP-DRC-MS)&#x0201d; Method No: 3018.3 (15 element panel) and 3018A.2 (total arsenic)</source>. <year>2012</year>.</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <article-title>National Health and Nutrition Examination Survey</article-title>, <source>2011-2012 Data Documentation, Codebook, and Frequencies, Arsenics - Total &#x00026; Speciated - Urine (UAS_G)</source>.</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <article-title>Laboratory Procedure Manual</article-title>, <source>Serum Multi-Element ICP-DRC-MS Method No: ICPDRCMS-3006.7</source>.</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <article-title>Laboratory Procedure Manual</article-title>, <source>Urine arsenic speciation HPLCICPDRCMS (Renamed from High Performance Liquid Chromatography Inductively Coupled Plasma Dynamic Reaction Cell Mass Spectrometry (HPLC-ICP-DRC-MS)) Method No: 3000.11 (Formerly 0161A/01-OD)</source>. <year>2011</year>.</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <article-title>Laboratory Procedure Manual</article-title>, <source>Urinary Creatinine</source></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AW</given-names></name>, <name><surname>Bruno</surname><given-names>RS</given-names></name>, and <name><surname>Traber</surname><given-names>MG</given-names></name>, <article-title>Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology</article-title>. <source>Lipids</source>, <year>2008</year>
<volume>43</volume>(<issue>10</issue>): p. <fpage>925</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">18751751</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><collab>Prevention, C.f.D.C.a.</collab>, <source>National Health and Nutrition Examination Survey: Analytic Guidelines</source>, <year>2011-2012</year>.</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Imai</surname><given-names>K</given-names></name>, <name><surname>Keele</surname><given-names>L</given-names></name>, and <name><surname>Yamamoto</surname><given-names>T</given-names></name>, <article-title>Identification, Inference and Sensitivity Analysis for Causal Mediation Effects</article-title>. <source>Statistical Science</source>, <year>2010</year>
<volume>25</volume>(<issue>1</issue>): p. <fpage>51</fpage>&#x02013;<lpage>71</lpage>.</mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Imai</surname><given-names>K</given-names></name>, <name><surname>Keele</surname><given-names>L</given-names></name>, and <name><surname>Tingley</surname><given-names>D</given-names></name>, <article-title>A general approach to causal mediation analysis</article-title>. <source>Psychol Methods</source>, <year>2010</year>
<volume>15</volume>(<issue>4</issue>): p. <fpage>309</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">20954780</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name><surname>Redwood</surname><given-names>D</given-names></name>, <etal/>, <article-title>Differences in cigarette and smokeless tobacco use among American Indian and Alaska Native people living in Alaska and the Southwest United States</article-title>. <source>Nicotine Tob Res</source>, <year>2010</year>
<volume>12</volume>(<issue>7</issue>): p. <fpage>791</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">20525781</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="book"><collab>Prevention, C.f.D.C.a.</collab>, <chapter-title>Fourth Report on Human Exposure to Environmental Chemicals</chapter-title>, <source>Updated Tables</source>, <publisher-name>U.S.D.o.H.a.H. Services</publisher-name>, Editor. <year>2017</year>: <publisher-loc>Atlanta, GA</publisher-loc>.</mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name><surname>Ishihara</surname><given-names>O</given-names></name>, <etal/>, <article-title>Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy</article-title>. <source>Free Radic Res</source>, <year>2004</year>
<volume>38</volume>(<issue>9</issue>): p. <fpage>913</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15621708</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name><surname>Palm</surname><given-names>M</given-names></name>, <etal/>, <article-title>F(2)-isoprostanes, tocopherols and normal pregnancy</article-title>. <source>Free Radic Res</source>, <year>2009</year>
<volume>43</volume>(<issue>6</issue>): p. <fpage>546</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">19384749</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="book"><collab>Agency, U.S.E.P.</collab>, <source>Addressing uranium contamination on the Navajo Nation</source>., <publisher-name>P.S.S. Program</publisher-name>, Editor. <year>2014</year>: <publisher-loc>San Francisco, CA</publisher-loc>.</mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name><surname>Okaneku</surname><given-names>J</given-names></name>, <etal/>, <article-title>Urine uranium concentrations and renal function in residents of the United States--2001 to 2010</article-title>. <source>Clin Toxicol (Phila)</source>, <year>2015</year>
<volume>53</volume>(<issue>10</issue>): p. <fpage>931</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">26468995</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name><surname>Brugge</surname><given-names>D</given-names></name> and <name><surname>Buchner</surname><given-names>V</given-names></name>, <article-title>Health effects of uranium: new research findings</article-title>. <source>Rev Environ Health</source>, <year>2011</year>
<volume>26</volume>(<issue>4</issue>): p. <fpage>231</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">22435323</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name><surname>Attreed</surname><given-names>SE</given-names></name>, <name><surname>Navas-Acien</surname><given-names>A</given-names></name>, and <name><surname>Heaney</surname><given-names>CD</given-names></name>, <article-title>Arsenic and Immune Response to Infection During Pregnancy and Early Life</article-title>. <source>Curr Environ Health Rep</source>, <year>2017</year>
<volume>4</volume>(<issue>2</issue>): p. <fpage>229</fpage>&#x02013;<lpage>243</lpage>.<pub-id pub-id-type="pmid">28488132</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name><surname>Sanchez</surname><given-names>TR</given-names></name>, <name><surname>Perzanowski</surname><given-names>M</given-names></name>, and <name><surname>Graziano</surname><given-names>JH</given-names></name>, <article-title>Inorganic arsenic and respiratory health, from early life exposure to sex-specific effects: A systematic review</article-title>. <source>Environ Res</source>, <year>2016</year>
<volume>147</volume>: p. <fpage>537</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">26891939</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name><surname>Cosselman</surname><given-names>KE</given-names></name>, <name><surname>Navas-Acien</surname><given-names>A</given-names></name>, and <name><surname>Kaufman</surname><given-names>JD</given-names></name>, <article-title>Environmental factors in cardiovascular disease</article-title>. <source>Nat Rev Cardiol</source>, <year>2015</year>
<volume>12</volume>(<issue>11</issue>): p. <fpage>627</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">26461967</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name><surname>Bjorklund</surname><given-names>G</given-names></name>, <etal/>, <article-title>Recent aspects of uranium toxicology in medical geology</article-title>. <source>Environ Res</source>, <year>2017</year>
<volume>156</volume>: p. <fpage>526</fpage>&#x02013;<lpage>533</lpage>.<pub-id pub-id-type="pmid">28431380</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name><surname>Duhig</surname><given-names>K</given-names></name>, <name><surname>Chappell</surname><given-names>LC</given-names></name>, and <name><surname>Shennan</surname><given-names>AH</given-names></name>, <article-title>Oxidative stress in pregnancy and reproduction</article-title>. <source>Obstet Med</source>, <year>2016</year>
<volume>9</volume>(<issue>3</issue>): p. <fpage>113</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">27630746</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name><surname>Maret</surname><given-names>W</given-names></name>, <article-title>Zinc biochemistry: from a single zinc enzyme to a key element of life</article-title>. <source>Adv Nutr</source>, <year>2013</year>
<volume>4</volume>(<issue>1</issue>): p. <fpage>82</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">23319127</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name><surname>Prasad</surname><given-names>AS</given-names></name>, <etal/>, <article-title>Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress</article-title>. <source>Am J Clin Nutr</source>, <year>2007</year>
<volume>85</volume>(<issue>3</issue>): p. <fpage>837</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">17344507</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name><surname>Izquierdo Alvarez</surname><given-names>S</given-names></name>, <etal/>, <article-title>Updating of normal levels of copper, zinc and selenium in serum of pregnant women</article-title>. <source>J Trace Elem Med Biol</source>, <year>2007</year>
<volume>21</volume>
<issue>Suppl 1</issue>: p. <fpage>49</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">18039497</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>R</given-names></name>, <etal/>, <article-title>A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women</article-title>. <source>Nutrients</source>, <year>2016</year>
<volume>8</volume>(<issue>11</issue>).</mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal"><name><surname>Wrzesniak</surname><given-names>M</given-names></name>, <etal/>, <article-title>The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy</article-title>. <source>PLoS One</source>, <year>2016</year>
<volume>11</volume>(<issue>8</issue>): p. <fpage>e0161342</fpage>.<pub-id pub-id-type="pmid">27548057</pub-id></mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal"><collab>International Zinc Nutrition Consultative, G.</collab>, <etal/>, <article-title>International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control</article-title>. <source>Food Nutr Bull</source>, <year>2004</year>
<volume>25</volume>(<issue>1 Suppl 2</issue>): p. <fpage>S99</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">18046856</pub-id></mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal"><name><surname>Tomey</surname><given-names>KM</given-names></name>, <etal/>, <article-title>Dietary fat subgroups, zinc, and vegetable components are related to urine F2a-isoprostane concentration, a measure of oxidative stress, in midlife women</article-title>. <source>J Nutr</source>, <year>2007</year>
<volume>137</volume>(<issue>11</issue>): p. <fpage>2412</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">17951478</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal"><name><surname>Dorjgochoo</surname><given-names>T</given-names></name>, <etal/>, <article-title>Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself</article-title>. <source>Am J Clin Nutr</source>, <year>2012</year>
<volume>96</volume>(<issue>2</issue>): p. <fpage>405</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">22760572</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal"><name><surname>Hopenhayn</surname><given-names>C</given-names></name>, <etal/>, <article-title>Profile of urinary arsenic metabolites during pregnancy</article-title>. <source>Environ Health Perspect</source>, <year>2003</year>
<volume>111</volume>(<issue>16</issue>): p. <fpage>1888</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">14644662</pub-id></mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal"><name><surname>Gibson</surname><given-names>RS</given-names></name>, <article-title>The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary requirement estimates</article-title>. <source>Food Nutr Bull</source>, <year>2007</year>
<volume>28</volume>(<issue>1 Suppl International</issue>): p. <fpage>S77</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">17521121</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>No difference in oxidative stress biomarkers by zinc status.</title><p id="P64">Participant results were separated by zinc status and analyzed for changes in the oxidative stress markers <bold>A.</bold> 8-iso-PGF<sub>2&#x003b1;</sub> and <bold>B.</bold> Prostaglandin ratio (8-iso PGF<sub>2&#x003b1;</sub>/ PGF<sub>2&#x003b1;</sub>)</p></caption><graphic xlink:href="nihms-1519174-f0002"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1.</label><caption><p id="P65">Selected demographic characteristics for NBCS participants</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="bottom" rowspan="1">Zinc Group<hr/></th><th align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Total (n = 132)</th><th align="center" valign="bottom" rowspan="1" colspan="1">High (n = 66)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Low (n = 66)</th><th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Median Age [IQR]</td><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">26.80 [22.33 - 31.2]</td><td align="center" valign="bottom" rowspan="1" colspan="1">26.35 [22.0 - 30.38]</td><td align="center" valign="bottom" rowspan="1" colspan="1">27.15 [22.5 - 31.2]</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.664<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Trimester stage (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">1st</td><td align="center" valign="bottom" rowspan="1" colspan="1">25 (18.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">25 (37.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">2nd</td><td align="center" valign="bottom" rowspan="1" colspan="1">59 (44.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">32 (48.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1">27 (40.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">3rd</td><td align="center" valign="bottom" rowspan="1" colspan="1">48 (36.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1">9 (13.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">39 (59.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Pre pregnancy BMI (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Normal<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="center" valign="bottom" rowspan="1" colspan="1">28 (21.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">13 (19.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">15 (22.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.536<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Overweight<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="center" valign="bottom" rowspan="1" colspan="1">37 (28.0)</td><td align="center" valign="bottom" rowspan="1" colspan="1">13 (19.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">24 (36.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Obese<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="center" valign="bottom" rowspan="1" colspan="1">32 (24.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">15 (22.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">17 (25.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Information</td><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">unavailable</td><td align="center" valign="bottom" rowspan="1" colspan="1">35 (26.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1">25 (37.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Vitamin usage (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">39 (29.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1">22 (33.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">17 (25.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.241<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">79 (59.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">34 (51.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1">45 (68.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Education above high school (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">65 (49.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">28 (42.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1">37 (56.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.385<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">51 (38.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">27 (40.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">24 (36.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">16 (12.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">11 (16.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">5 (7.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Annual household income &#x0003c;$20,000 (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">41 (31.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">23 (34.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">18 (27.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.182<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">57 (43.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">23 (34.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">34 (51.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">34 (25.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">20 (30.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (21.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Currently unemployed (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">42 (31.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">24 (36.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1">18 (27.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.17<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">76 (57.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">32 (48.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1">44 (66.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Alcohol usage in the past year (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">84 (63.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">42 (63.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">42 (63.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.506<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">34 (25.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (21.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">20 (30.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Cigarette usage (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Never Smoked</td><td align="center" valign="bottom" rowspan="1" colspan="1">89 (67.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1">38 (57.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">51 (77.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.018<sup><xref rid="TFN5" ref-type="table-fn">d</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Current Smoker</td><td align="center" valign="bottom" rowspan="1" colspan="1">1 (0.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0 (0.0)</td><td align="center" valign="bottom" rowspan="1" colspan="1">1 (1.5)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Former Smoker</td><td align="center" valign="bottom" rowspan="1" colspan="1">16 (12.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">12 (18.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">26 (19.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">16 (24.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Ceremonial tobacco usage (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">73 (55.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">38 (57.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">35 (53.0)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.278<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">45 (34.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">18 (27.3)</td><td align="center" valign="bottom" rowspan="1" colspan="1">27 (40.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Wood used for home heating (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">70 (53.0)</td><td align="center" valign="bottom" rowspan="1" colspan="1">29 (43.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">41 (62.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.163<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">48 (36.4)</td><td align="center" valign="bottom" rowspan="1" colspan="1">27 (40.9)</td><td align="center" valign="bottom" rowspan="1" colspan="1">21 (31.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Coal used for home heating (%)</td><td align="left" valign="bottom" rowspan="1" colspan="1">No</td><td align="center" valign="bottom" rowspan="1" colspan="1">28 (21.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">11 (16.7)</td><td align="center" valign="bottom" rowspan="1" colspan="1">17 (25.8)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.438<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Yes</td><td align="center" valign="bottom" rowspan="1" colspan="1">90 (68.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">45 (68.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">45 (68.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">No Response</td><td align="center" valign="bottom" rowspan="1" colspan="1">14 (10.6)</td><td align="center" valign="bottom" rowspan="1" colspan="1">10 (15.2)</td><td align="center" valign="bottom" rowspan="1" colspan="1">4 (6.1)</td><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P66">Abbreviations: BMI, body mass index; IQR, interquartile range</p></fn><fn id="TFN2"><label>a</label><p id="P67">Wilcoxon rank sum test was used to calculate the P-value comparing low vs. high zinc groups.</p></fn><fn id="TFN3"><label>b</label><p id="P68">Chi-square tests were used to calculate the P-value comparing low vs. high zinc groups.</p></fn><fn id="TFN4"><label>c</label><p id="P69">BMI defined as Normal (18.5 - 24.9 kg/m2), Overweight (25 - 29.9 kg/m2), and Obese (&#x0003e;30 kg/m2)</p></fn><fn id="TFN5"><label>d</label><p id="P70">Fisher Exact tests were used to calculate the P-value comparing low vs. high zinc groups.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2.</label><caption><p id="P71">Summary of metal levels in the NBCS population</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="middle" rowspan="1">Zinc Group<hr/></th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Metals</th><th align="center" valign="middle" rowspan="1" colspan="1">NHANES<sup><xref rid="TFN7" ref-type="table-fn">a</xref></sup> Median<break/>[IQR]</th><th align="center" valign="middle" rowspan="1" colspan="1">NBCS Median<break/>[IQR]</th><th align="center" valign="middle" rowspan="1" colspan="1">% Below<break/>LOD</th><th align="center" valign="middle" rowspan="1" colspan="1">High [IQR]</th><th align="center" valign="middle" rowspan="1" colspan="1">Low [IQR]</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Uranium (&#x003bc;g/g creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007 [0.005 &#x02212;0.013]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.016 [0.0098 - 0.025]</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013 [0.0094 - 0.021]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.017 [0.011 - 0.027]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total Arsenic (&#x003bc;g/g creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.6 [4.2-15.0]</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5 [4.2-8.2]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">5.1 [4.1 &#x02013; 7.9]</td><td align="center" valign="middle" rowspan="1" colspan="1">5.9 [4.8 - 8.6]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMA (&#x003bc;g/g creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1 [2.7-6.7]</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3 [2.9-5.8]</td><td align="center" valign="middle" rowspan="1" colspan="1">20.5</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9 [2.6-5.2]</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6 [3.2-6.2]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AsIII (&#x003bc;g/g creatinine)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;LOD [&#x0003c; LOD - &#x0003c;LOD]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41 [0.019-0.58]</td><td align="center" valign="middle" rowspan="1" colspan="1">33.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43 [0.24 - 0.58]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37 [0.16-0.58]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Zinc (&#x003bc;g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">80 [72 &#x02212;88 ]</td><td align="center" valign="middle" rowspan="1" colspan="1">67 [48.0 - 78.0]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0</td><td align="center" valign="middle" rowspan="1" colspan="1">78 [74.0 - 85.0]</td><td align="center" valign="middle" rowspan="1" colspan="1">48 [44 -51]</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p id="P72">Abbreviations: NBCS, Navajo Birth Cohort Study; NHANES, National Health and Nutrition Examination Survey; LOD, limit of detection; IQR, interquartile range; DMA, dimethylarsinic acid; AsIII, arsenite</p></fn><fn id="TFN7"><label>a</label><p id="P73">Summary statistics were based on 2011-2012 NHANES dataset restricted to women; Urine chemical measurements were corrected for creatinine.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3.</label><caption><p id="P74">Distribution of metals by trimester.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Metal</th><th align="center" valign="middle" rowspan="1" colspan="1">Trimester</th><th align="center" valign="middle" rowspan="1" colspan="1">n</th><th align="center" valign="middle" rowspan="1" colspan="1">Median [IQR]</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN9" ref-type="table-fn">a</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Uranium (&#x003bc;g/g creatinine)</td><td align="center" valign="top" rowspan="1" colspan="1">1st</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">0.014 [0.010 - 0.021]</td><td align="center" valign="top" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2nd</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">0.016 [0.009 - 0.024]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">3rd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">0.016 [0.011 - 0.026]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total Arsenic (&#x003bc;g/g creatinine)</td><td align="center" valign="top" rowspan="1" colspan="1">1st</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">4.992 [4.097 - 7.910]</td><td align="center" valign="top" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2nd</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">5.573 [4.293 - 8.287]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">3rd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">5.723 [4.565 - 8.632]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DMA (&#x003bc;g/g creatinine)</td><td align="center" valign="top" rowspan="1" colspan="1">1st</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">3.460 [2.629 - 5.806]</td><td align="center" valign="top" rowspan="1" colspan="1">0.357</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2nd</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">4.572 [2.802 - 5.894]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">3rd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">4.307 [3.177 - 5.750]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AsIII (&#x003bc;g/g creatinine)</td><td align="center" valign="top" rowspan="1" colspan="1">1st</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">0.535 [0.379 - 0.892]</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.0017</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2nd</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">0.442 [0.257 - 0.574]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">3rd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">0.259 [0.137-0.482]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zinc (&#x003bc;g/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">1st</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">77 [74.0 - 82.9]</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.78E-11</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">2nd</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">72 [49.65 - 82.0]</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">3rd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">49.95 [44.075 - 52.851</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN8"><p id="P75">Abbreviations: IQR, interquartile range; DMA, dimethylarsinic acid; AsIII, arsenite</p></fn><fn id="TFN9"><label>a</label><p id="P76">P-values were calculated using one-way ANOVA F test of the log transformed chemical exposures among three trimesters.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4:</label><caption><p id="P77">Summary statistics for oxidative stress outcome variables.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Overall</th><th align="center" valign="middle" rowspan="1" colspan="1">First Trimester</th><th align="center" valign="middle" rowspan="1" colspan="1">Second Trimester</th><th align="center" valign="middle" rowspan="1" colspan="1">Third Trimester</th><th align="center" valign="middle" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Unit<sup><xref rid="TFN12" ref-type="table-fn">b</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Median [IQR]</td><td align="center" valign="top" rowspan="1" colspan="1">Median [IQR]</td><td align="center" valign="top" rowspan="1" colspan="1">Median [IQR]</td><td align="center" valign="top" rowspan="1" colspan="1">Median [IQR]</td><td align="center" valign="top" rowspan="1" colspan="1"><italic><bold>p</bold></italic><sup><xref rid="TFN13" ref-type="table-fn">c</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>8-isoPGF<sub>2a</sub></bold></td><td align="center" valign="top" rowspan="1" colspan="1">ng/g creatinine</td><td align="center" valign="top" rowspan="1" colspan="1">935 [708 - 1201]</td><td align="center" valign="top" rowspan="1" colspan="1">918 [674 - 1162]</td><td align="center" valign="top" rowspan="1" colspan="1">881 [699 - 1219]</td><td align="center" valign="top" rowspan="1" colspan="1">1009 [850 - 1171]</td><td align="center" valign="top" rowspan="1" colspan="1">0.4633</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>prostaglandin-F<sub>2a</sub></bold></td><td align="center" valign="top" rowspan="1" colspan="1">ng/g creatinine</td><td align="center" valign="top" rowspan="1" colspan="1">3897 [2952 - 5373]</td><td align="center" valign="top" rowspan="1" colspan="1">3225 [2571 - 4073]</td><td align="center" valign="top" rowspan="1" colspan="1">3892 [2985 - 5058]</td><td align="center" valign="top" rowspan="1" colspan="1">4929 [3572 - 6905]</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.0013</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Prostaglandin Ratio</bold><sup><xref rid="TFN11" ref-type="table-fn">a</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">0.25 [0.18 - 0.31]</td><td align="center" valign="top" rowspan="1" colspan="1">0.30 [0.27 - 0.32]</td><td align="center" valign="top" rowspan="1" colspan="1">0.25 [0.19 - 0.30]</td><td align="center" valign="top" rowspan="1" colspan="1">0.20 [0.16 - 0.29]</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.0036</bold></td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><p id="P78">Abbreviations: IQR, interquartile range</p></fn><fn id="TFN11"><label>a</label><p id="P79">Ratio of 8-isoPGF<sub>2a</sub> to PGF<sub>2a</sub> .</p></fn><fn id="TFN12"><label>b</label><p id="P80">Measurements were corrected for urine creatinine.</p></fn><fn id="TFN13"><label>c</label><p id="P81">Kruskal-Wallis tests were used to calculate the p-value comparing different trimesters.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float" orientation="portrait"><label>Table 5.</label><caption><p id="P82">Regression coefficients of metal exposure, income, and ceremonial tobacco use for oxidative stress biomarker 8-isoPGF2&#x003b1;.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">Univariable</th><th colspan="3" align="center" valign="middle" rowspan="1">Multivariable<sup><xref rid="TFN18" ref-type="table-fn">d</xref></sup></th></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td colspan="6" align="center" valign="top" rowspan="1"><hr/></td></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Variable <sup><xref rid="TFN15" ref-type="table-fn">a</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient <sup><xref rid="TFN16" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Standard Error <sup><xref rid="TFN16" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN17" ref-type="table-fn">c</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient</th><th align="center" valign="middle" rowspan="1" colspan="1">Standard Error</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN17" ref-type="table-fn">c</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Uranium</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.044</td><td align="center" valign="middle" rowspan="1" colspan="1">0.044</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.097</td><td align="center" valign="middle" rowspan="1" colspan="1">0.066</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total Arsenic</td><td align="center" valign="middle" rowspan="1" colspan="1">0.066</td><td align="center" valign="middle" rowspan="1" colspan="1">0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.341</td><td align="center" valign="middle" rowspan="1" colspan="1">0.133</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.012</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Low Zinc</td><td align="center" valign="middle" rowspan="1" colspan="1">0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">0.066</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.679</td><td align="center" valign="middle" rowspan="1" colspan="1">0.327</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.041</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total As/Zinc Group Interaction</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.380</td><td align="center" valign="middle" rowspan="1" colspan="1">0.181</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.038</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Annual Household Income &#x0003c;$20,000</td><td align="center" valign="middle" rowspan="1" colspan="1">0.158</td><td align="center" valign="middle" rowspan="1" colspan="1">0.078</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.044</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">0.168</td><td align="center" valign="middle" rowspan="1" colspan="1">0.076</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.030</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ceremonial Tobacco Use</td><td align="center" valign="middle" rowspan="1" colspan="1">0.167</td><td align="center" valign="middle" rowspan="1" colspan="1">0.071</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.021</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">0.142</td><td align="center" valign="middle" rowspan="1" colspan="1">0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">0.076</td></tr></tbody></table><table-wrap-foot><fn id="TFN14"><p id="P83">Abbreviations: DMA, dimethylarsinic acid</p></fn><fn id="TFN15"><label>a</label><p id="P84">Metals were log transformed. Zinc was a binary variable. Outcome variable (8-isoPGF<sub>2&#x003b1;</sub>) was log transformed.</p></fn><fn id="TFN16"><label>b</label><p id="P85">The estimates of the regression coefficients and the standard errors from the linear regression models.</p></fn><fn id="TFN17"><label>c</label><p id="P86">P-values were calcuated using t tests.</p></fn><fn id="TFN18"><label>d</label><p id="P87">Multivariable model with backward selection using AIC criteria modeling the relationship between metals and oxidative stress biomarker 8-isoPGF<sub>2&#x003b1;</sub>. R<sup>2</sup>=0.15.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T6" position="float" orientation="portrait"><label>Table 6.</label><caption><p id="P88">Regression coefficients of metal exposure, education, ceremonial tobacco use and trimester for the prostaglandin ratio.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">Univariable</th><th colspan="3" align="center" valign="middle" rowspan="1">Multivariable <sup><xref rid="TFN23" ref-type="table-fn">d</xref></sup></th></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td colspan="6" align="left" valign="middle" rowspan="1"><hr/></td></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Variable <sup><xref rid="TFN20" ref-type="table-fn">a</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient <sup><xref rid="TFN21" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Standard Error <sup><xref rid="TFN21" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN22" ref-type="table-fn">c</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient</th><th align="center" valign="middle" rowspan="1" colspan="1">Standard<break/>Error</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN22" ref-type="table-fn">c</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Uranium</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" rowspan="1" colspan="1">0.010</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.055</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total Arsenic</td><td align="center" valign="middle" rowspan="1" colspan="1">0.031</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.096</td><td align="center" valign="middle" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DMA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.01</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Uranium/Total Arsenic Interaction</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.036</td><td align="center" valign="middle" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Low Zinc Group</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0.320</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education above high school</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.024</td><td align="center" valign="middle" rowspan="1" colspan="1">0.017</td><td align="center" valign="middle" rowspan="1" colspan="1">0.157</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.049</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ceremonial Tobacco Use</td><td align="center" valign="middle" rowspan="1" colspan="1">0.035</td><td align="center" valign="middle" rowspan="1" colspan="1">0.016</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.037</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">0.035</td><td align="center" valign="middle" rowspan="1" colspan="1">0.016</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.026</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2nd Trimester</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.057</td><td align="center" valign="middle" rowspan="1" colspan="1">0.020</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.004</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.052</td><td align="center" valign="middle" rowspan="1" colspan="1">0.021</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.017</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3rd Trimester</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">0.020</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.00016</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.089</td><td align="center" valign="middle" rowspan="1" colspan="1">0.022</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.00009</bold></td></tr></tbody></table><table-wrap-foot><fn id="TFN19"><p id="P89">Abbreviations: DMA, dimethylarsinic acid</p></fn><fn id="TFN20"><label>a</label><p id="P90">Metals were log transformed.</p></fn><fn id="TFN21"><label>b</label><p id="P91">The estimates of the regression coefficients and the standard errors from the linear regression models.</p></fn><fn id="TFN22"><label>c</label><p id="P92">P-values were calcuated using t tests.</p></fn><fn id="TFN23"><label>d</label><p id="P93">Final multivariable model with backward selection using AIC criteria modeling the relationship between chemicals and oxidative stress biomarker ratio. R<sup>2</sup>=0.23.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T7" position="float" orientation="portrait"><label>Table 7.</label><caption><p id="P94">Regression coefficients of total arsenic and the oxidative stress biomarker 8-isoPGF<sub>2&#x003b1;</sub>, stratified by zinc group.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">Low Zinc group</th><th colspan="3" align="center" valign="middle" rowspan="1">High Zinc group</th></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td colspan="6" align="left" valign="middle" rowspan="1"><hr/></td></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Variable <sup><xref rid="TFN24" ref-type="table-fn">a</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient <sup><xref rid="TFN25" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Standard<break/>Error <sup><xref rid="TFN25" ref-type="table-fn">b</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN26" ref-type="table-fn">c</xref></sup></th><th align="center" valign="middle" rowspan="1" colspan="1">Coefficient</th><th align="center" valign="middle" rowspan="1" colspan="1">Standard<break/>Error</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic><sup><xref rid="TFN26" ref-type="table-fn">c</xref></sup></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total Arsenic</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.045</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.018</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Annual Household Income &#x0003c;$20,000</td><td align="center" valign="middle" rowspan="1" colspan="1">0.097</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.35</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.040</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ceremonial Tobacco Use</td><td align="center" valign="middle" rowspan="1" colspan="1">0.099</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td></tr></tbody></table><table-wrap-foot><fn id="TFN24"><label>a</label><p id="P95">Metals were log transformed. Zinc was a binary variable. Outcome variable (8-isoPGF<sub>2&#x003b1;</sub>) was log transformed.</p></fn><fn id="TFN25"><label>b</label><p id="P96">The estimates of the regression coefficients and the standard errors from the linear regression models.</p></fn><fn id="TFN26"><label>c</label><p id="P97">P-values were calcuated using t tests.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Highlights</title></caption><list list-type="bullet" id="L2"><list-item><p id="P98">Urinary uranium, but not arsenic, is elevated in the study participants compared to NHANES.</p></list-item><list-item><p id="P99">Arsenic is associated with increased levels of urinary 8-iso-prostaglandin F<sub>2&#x003b1;</sub>.</p></list-item><list-item><p id="P100">Uranium is not associated with elevated urinary F<sub>2</sub>-isoprostanes.</p></list-item><list-item><p id="P101">Zinc was not found to have any causal mediation of the effects of the other metals on oxidative stress.</p></list-item></list></boxed-text></floats-group></article>